Navigo Proteins GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Navigo Proteins GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11526
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Navigo Proteins GmbH (Navigo Proteins), formerly Scil Proteins GmbH, a subsidiary of UV-Cap GmbH & Co KG, is a protein engineering company that offers generation and optimization of proteins for therapeutic and non-therapeutics. The company provides microbial production of recombinant proteins. Its business areas include development of drug conjugates oncology indications, multi-specific protein binding molecules, and ligands for non-therapeutic applications. Navigo Proteins develops Affilin, a based molecules are derived from a human scaffold protein for generation of radio conjugates. The company serves pharmaceutical, biotech and life science industries. Navigo Proteins is headquartered in Halle, Germany.

Navigo Proteins GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navigo Proteins GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Navigo Proteins GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
UV-Cap Acquires Scil Proteins from Bionet Ventures 11
Partnerships 12
Natrix Separations Enters into Co-Development Agreement with Scil Proteins 12
Isotopen Technologien Munchen and Scil Proteins Enter into Partnership 13
Ono Pharma Enters Into Co-Development Agreement With Scil Proteins For Affilin Therapeutics 14
Navigo Proteins GmbH – Key Competitors 15
Navigo Proteins GmbH – Key Employees 16
Navigo Proteins GmbH – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navigo Proteins GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navigo Proteins GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Navigo Proteins GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
UV-Cap Acquires Scil Proteins from Bionet Ventures 11
Natrix Separations Enters into Co-Development Agreement with Scil Proteins 12
Isotopen Technologien Munchen and Scil Proteins Enter into Partnership 13
Ono Pharma Enters Into Co-Development Agreement With Scil Proteins For Affilin Therapeutics 14
Navigo Proteins GmbH, Key Competitors 15
Navigo Proteins GmbH, Key Employees 16

List of Figures
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Navigo Proteins GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Navigo Proteins GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Select Medical Holdings Corporation:企業の戦略・SWOT・財務分析
    Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Devon Energy Corporation (DVN)-石油・ガス分野:企業M&A・提携分析
    Summary Devon Energy Corporation (Devon Energy) is an independent energy company. The company carries out exploration, development, and production of oil, natural gas and natural gas liquids (NGLs). It has its operations in onshore areas of the US and Canada. Devon Energy’s US assets are located in …
  • Software AG:企業の戦略・SWOT・財務情報
    Software AG - Strategy, SWOT and Corporate Finance Report Summary Software AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • DJO Global Inc:医療機器:M&Aディール及び事業提携情報
    Summary DJO Global Inc. (DJO) is a medical device company. The company engages in provision of orthopaedic devices. DIO develops, manufactures and distributors orthopaedic devices for musculoskeletal health, vascular health and pain management solutions. The company products include rigid and soft o …
  • East Central Energy:企業の発電所・SWOT分析2018
    East Central Energy - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Aegion Corp (AEGN):企業の財務・戦略的SWOT分析
    Aegion Corp (AEGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Rizal Commercial Banking Corp (RCB):企業の財務・戦略的SWOT分析
    Summary Rizal Commercial Banking Corp (RCBC) is a commercial and financial banking service provider that offers corporate, commercial, and consumer banking, cash management, treasury, and remittance products and services. The company’s electronic banking services include mobile banking, internet ban …
  • Aprima Medical Software Inc-医療機器分野:企業M&A・提携分析
    Summary Aprima Medical Software Inc (Aprima) is an information technology service provider for pharmaceutical sector. The company’s solutions include EHR, practice management, and revenue cycle management. Its EHR solutions provide patient engagement, mobility, clinical decision support, integrated …
  • Royal Dutch Shell Plc (RDSA):企業の財務・戦略的SWOT分析
    Royal Dutch Shell Plc (RDSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • CIMIC Group Limited:企業の戦略・SWOT・財務情報
    CIMIC Group Limited - Strategy, SWOT and Corporate Finance Report Summary CIMIC Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ELITechGroup Inc-医療機器分野:企業M&A・提携分析
    Summary ELITechGroup Inc (ELITech) is a medical device company that manufactures and distributes in vitro diagnostic equipment and reagents. The company’s products portfolio includes clinical chemistry, cytology, hematology, immunology, microbiology and molecular diagnostics. Its clinical chemistry …
  • State Oil Company of the Azerbaijan Republic:石油・ガス:M&Aディール及び事業提携情報
    Summary State Oil Company of the Azerbaijan Republic (SOCAR) is an oil and gas exploration company. The company explores oil and gas fields; and produces, processes and transports oil, gas and gas condensate. It markets petroleum and petrochemical products in domestic and international markets and s …
  • Smithfield Foods Inc:企業のM&A・事業提携・投資動向
    Smithfield Foods Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Smithfield Foods Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Icon Genetics GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Icon Genetics GmbH (Icon Genetics) a subsidiary of Bayer AG is a biotechnology company that offers plant engineering technologies. The company develops, manufactures and markets biopharmaceutical product candidates, engineered organisms and technology platforms for plant biotechnology and pl …
  • Aegis Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Aegis Therapeutics LLC (Aegis Therapeutics) is a biotechnology company that research and develops drug delivery and drug formulation technologies. The company commercializes new drug delivery and protein stabilization technologies through product specific licenses to pharmaceutical and bioph …
  • Autodesk Inc:戦略・SWOT・企業財務分析
    Autodesk Inc - Strategy, SWOT and Corporate Finance Report Summary Autodesk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Prometheus Energy Group Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Prometheus Energy Group Inc (Prometheus) is an oil and gas company that supplies liquefied natural gas. The company offers services such as LNG conversion solutions, LNG storage and supply, turnkey fuel solutions, logistics and distribution, and storage, re-gas and field service. It offers t …
  • Cidara Therapeutics Inc (CDTX):企業の財務・戦略的SWOT分析
    Summary Cidara Therapeutics Inc (Cidara), formerly K2 Therapeutics Inc is a biotechnology company that discovers, develops and commercializes novel anti-infectives including immunotherapies. The company's pipeline products include novel echinocandin CD101 IV, for the treatment of systemic candida in …
  • Advance Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Advance Pharmaceutical Co Ltd (APC), formerly Dang Ling is a healthcare products provider that manufactures and distributes prescription and over the counter pharmaceutical products. The company’s products include vitamins and supplements, cough syrups, skin care, disinfectant liquids, and r …
  • Narodowy Bank Polski:企業の戦略的SWOT分析
    Narodowy Bank Polski - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆